Michiaki Yoneda

Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (5). In Vitro Metabolism and Plasma Protein Binding in Animals and Human.

Hideki Fujino, Iwao Yamada, Junji Kojima et al. · Drug Metabolism and Pharmacokinetics · 1999 · 36 citations · Full text

Medicine, Biochemistry, Pharmacology +16

Metabolic Fate of Pitavastatin (NK-104), a New Inhibitor of 3-Hydroxy-3-methyllutaryl Coenzyme A Reductase

Hideki Fujino, Iwao Yamada, Syunsuke Shimada et al. · Arzneimittelforschung · 2011 · 32 citations

Medicine, Biochemistry, Pharmacology +16

Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay — inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase

Hideki Fujino, Iwao Yamada, Syunsuke Shimada et al. · Journal of Chromatography B Biomedical Sciences and Applications · 2001 · 25 citations

Life Sciences, Biochemistry, Pharmacology +9

Mass spectrometric studies on chemiluminescence of coelenterate luciferin analogues

Takashi Hirano, Sadatoshi Nisbibuchi, Michiaki Yoneda et al. · Tetrahedron · 1993 · 17 citations

Natural Sciences, Biophysics, Chemistry +10

Effect of Biliary Excretion on the Pharmacokinetics of Pitavastatin (NK-104) in Dogs.

Junji Kojima, T. Ohshima, Michiaki Yoneda et al. · Drug Metabolism and Pharmacokinetics · 2001 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13